S. Kim

Carbohydrate vaccines in cancer: Immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man

Susan F. Slovin, Govindaswami Ragupathi, Sucharita Adluri et al. · Proceedings of the National Academy of Sciences · 1999 · 253 citations · Full text

Immunocytochemical Technique, Immunology, Immunoediting +19

Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial

Bernard Escudier, M. Dror Michaelson, Robert J. Motzer et al. · British Journal of Cancer · 2014 · 102 citations · Full text

A Phase II trial of axitinib in patients with various histologic subtypes of advanced thyroid cancer: long-term outcomes and pharmacokinetic/pharmacodynamic analyses

Ezra E.W. Cohen, Michael A. Tortorici, S. Kim et al. · Cancer Chemotherapy and Pharmacology · 2014 · 50 citations · Full text

Diastolic blood pressure (dBP) and pharmacokinetics (PK) as predictors of axitinib efficacy in metastatic renal cell cancer (mRCC)

Olivier Rixe, Janice P. Dutcher, Robert J. Motzer et al. · Journal of Clinical Oncology · 2009 · 47 citations

Dbp Elevation, Hypertension, Pharmacotherapy +20

Randomised phase II study of axitinib or bevacizumab combined with paclitaxel/carboplatin as first-line therapy for patients with advanced non-small-cell lung cancer

Chris Twelves, Ewa Chmielowska, Libor Havel et al. · Annals of Oncology · 2013 · 34 citations